AP Biosciences (ROCO:6945) FCF Yield % : -8.70 (As of Jun. 17, 2024)

View and export this data going back to 2023. Start your Free Trial

What is AP Biosciences FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, AP Biosciences's Trailing 12-Month Free Cash Flow is NT$-333.03 Mil, and Market Cap is NT$3,827.38 Mil. Therefore, AP Biosciences's FCF Yield % for today is -8.70%.

The historical rank and industry rank for AP Biosciences's FCF Yield % or its related term are showing as below:

ROCO:6945' s FCF Yield % Range Over the Past 10 Years
Min: -11.3 Med: -7.99 Max: -4.56
Current: -8.7

During the past 4 years, the highest FCF Yield % of AP Biosciences was -4.56%. The lowest was -11.30%. And the median was -7.99%.

ROCO:6945's FCF Yield % is ranked better than
60.77% of 1550 companies
in the Biotechnology industry
Industry Median: -13.97 vs ROCO:6945: -8.70

AP Biosciences's FCF Margin % for the quarter that ended in Dec. 2023 was -710.17%.

AP Biosciences FCF Yield % Historical Data

The historical data trend for AP Biosciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AP Biosciences FCF Yield % Chart

AP Biosciences Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Yield %

-11.04

AP Biosciences Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial			-	-	-	-	-15.18

Competitive Comparison of AP Biosciences's FCF Yield %

For the Biotechnology subindustry, AP Biosciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AP Biosciences's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AP Biosciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where AP Biosciences's FCF Yield % falls into.

AP Biosciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

AP Biosciences's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-333.029	/	3017.2568
	=	-11.04%

AP Biosciences's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-229.052	*	2	/	3017.2568
	=	-15.18%

AP Biosciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

AP Biosciences FCF Yield % Related Terms

Thank you for viewing the detailed overview of AP Biosciences's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

AP Biosciences (ROCO:6945) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3, Park Street, 17th Floor, Taipei, TWN

Website

https://www.apbioinc.com

AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.

AP Biosciences (ROCO:6945) Headlines

No Headlines